Uscom Limited has released a press release.
Uscom New SpiroSonic Series of Asthma Products
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Uscom
- Uscom: Uscom signs 5 year $7m China sales deal
- Successful capital raising to support new sales and distribution initiatives
- Uscom: Uscom Completes Pulsecor Asset Purchase and Acquires New BP+ Central Blood Pressure Device
- Uscom: Uscom progress report - Pulsecor acquisition
- Uscom to Acquire Pulsecor and New Blood Pressure Products
Later from Uscom
- Uscom BP Plus equal to catheters for Central BP in children
- Uscom BP plus Contracted Into UK NHS Supply Chain
- Paediatric sepsis mortality reduced 46% with USCOM use
- Uscom may improve outcomes and reduce cost in surgery
- Oversubscribed PP for Strategic Investment
Follow Uscom into a list and get an email when it puts out news.
Follow Uscom